Showing results (1201-1210 of 1,878) with videos related to

Sort By:
Pageof 188
Immunotherapy|December 13, 2019
Abscopal effect in lung cancer: three case reports and a concise reviewElena Garelli, Achim Rittmeyer, Paul Martin Putora, et al.
Immunotherapy|March 27, 2020
Exploiting antibody biology for the treatment of cancerVidhi Khanna, Jayanth Panyam, Thomas S Griffith
Immunotherapy|March 28, 2020
Efficacy and safety of octanorm (cutaquig®) in adults with primary immunodeficiencies with predominant antibody deficiency: a prospective, open-label studyElena Latysheva, Yulia Rodina, Liudmila Sizyakina, et al.
Immunotherapy|April 3, 2020
Toll-like receptors as a therapeutic target in cancer, infections and inflammatory diseasesLizdany Flórez-Álvarez, Lanie Ruiz-Perez, Natalia Taborda, et al.
Immunotherapy|October 13, 2020
Pseudoprogression of extramedullary disease in relapsed acute lymphoblastic leukemia after CAR T-cell therapyJie Huang, Liucheng Rong, Enxiu Wang, et al.
Immunotherapy|October 5, 2020
Smoking status-based efficacy difference in anti-PD-1/PD-L1 immunotherapy: a systematic review and meta-analysisRun-Cong Nie, Jin-Ling Duan, Yao Liang, et al.
Immunotherapy|October 1, 2020
Designing novel immunocombinations in metastatic renal cell carcinomaMatteo Santoni, Francesco Massari, Gaetano Aurilio, et al.
Immunotherapy|January 12, 2019
Tuberculosis, hepatitis B and herpes zoster in tofacitinib-treated patients with rheumatoid arthritisZhuoya Zhang, Wei Deng, Qizhe Wu, et al.
Immunotherapy|December 1, 2018
Safety and efficacy of intravenous immunoglobulin (Flebogamma® 10% DIF) in patients with immune thrombocytopenic purpuraShashikant Apte, Jordi Navarro-Puerto, Sharat Damodar, et al.
Immunotherapy|October 31, 2019
Immunotherapy in renal cell carcinoma from poverty to the spoiled of choiceFrancesco Massari, Vincenzo Di Nunno, Veronica Mollica, et al.
Pageof 188